An Extension Study of V203-AD Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UB-311
Clinical trial NCT03531710 · TERMINATED
Trial details
- NCT number
- NCT03531710
- Sponsor
- United Neuroscience Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-10
- Primary completion
- 2019-10-31
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.